Physician profile
Ashley Michael
NPI 1831553551
$6,792.03
in general payments reported to CMS, 2019-2025
20 companies · $565 in 2025
The $565 reported for 2025 was more than what 81% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $138 · 2021: $649 · 2022: $1,328 · 2023: $2,588 · 2024: $1,523 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,611 · Travel and Lodging: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,611.05 |
| Travel and Lodging | $1,065.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,298.72 | 2021-2025 | Eterna, Proclaim, Axium |
| Relievant Medsystems, INC. | $1,311.31 | 2023 | Intracept |
| Spr Therapeutics, INC | $377.80 | 2021-2025 | Sprint Pns System |
| Vertos Medical, INC. | $250.36 | 2022-2024 | Mild Device Kit |
| Nevro Corp. | $247.30 | 2021-2023 | Senza |
| Avanos Medical | $240.09 | 2021 | |
| Stratus Medical, LLC | $196.57 | 2023 | Nimbus |
| Medtronic, INC. | $159.73 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $141.17 | 2024-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Stryker Corporation | $84.80 | 2020-2024 | Mild Device Kit |
| Nalu Medical, INC. | $77.48 | 2023-2025 | Nalu Neurostimulation System |
| Mml US, INC. | $65.39 | 2023 | Reactiv8 |
| Painteq LLC | $53.59 | 2023 | Painteq |
| Hydrocision, INC. | $50.45 | 2024 | Tenjet |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $46.58 | 2024-2025 | |
| Averitas Pharma INC. | $46.37 | 2024-2025 | Qutenza |
| E.R. Squibb & Sons, L.L.C. | $20.13 | 2025 | Camzyos |
| Globus Medical, INC. | $19.69 | 2025 | Senza |
| Saluda Medical Americas, INC. | $12.00 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.